Oral Presentation Smart Strokes Annual Scientific Meeting 2025

Adapting Group Aphasia Therapy for Online Delivery: Multi-Modality Aphasia Therapy Tele (127693)

John E Pierce 1 2 , Emily Eley 1 2 , Annie J Hill 1 2 , Dana Wong 1 , Rachelle Pitt 3 , Miranda Rose 1 2
  1. La Trobe University, Bundoora, VIC, Australia
  2. Centre of Research Excellence in Aphasia Rehabilitation and Recovery, Australia
  3. University of Queensland, Herston, QLD, Australia

Introduction: Multi-Modality Aphasia Treatment (M-MAT) is an established group-based aphasia intervention with effectiveness previously demonstrated in a phase III trial[1]. Adapting M-MAT for telehealth would overcome geographical and logistical barriers to implementation, making therapy more accessible to people with aphasia. The aim of this project was to co-design and test a telehealth adaptation of M-MAT (M-MAT Tele) that meets the requirements of practicing speech pathologists and individuals with aphasia while leveraging telehealth advantages.

Methods: This project involved two phases. In phase one, a Human-Centred Design approach was employed with practising speech pathologists (n=3) and people with aphasia (n=3). Desirable features, context of use, and hardware and software requirements were established. Software was co-designed iteratively through ongoing workshops. Phase two was a pilot trial of M-MAT-Tele in three groups of people with chronic aphasia (n=9). Feasibility and acceptability were explored through a range of measure and clinical outcomes were examined through effect sizes (Cohen’s d).

Result: Phase one produced novel software and a treatment protocol for M-MAT Tele that aligns with key user requirements: compatible with most videoconference platforms, minimal hardware and software requirements, and maximum usability for participants, while containing core elements of in-person M-MAT. Pilot trial data indicated the intervention was feasible and acceptable, with participants highlighting positive experiences with the group-based format. Large effect sizes were seen on word retrieval (1.952), communicative quality of life (1.196) and everyday communication (1.047).

Conclusion: The adaptation of M-MAT for telehealth successfully met the complex requirements of clinicians and people with aphasia. Pilot data support the feasibility and acceptability of M-MAT Tele and clinical outcomes suggest potential efficacy. Further evaluation in a randomized controlled trial is warranted.

Relevance to clinical practice or patient experience: Given its proven underlying treatment approach, M-MAT Tele could offer an accessible, evidence-based and interactive aphasia treatment for people unable to attend in-person therapy.

  1. Rose, M. L., Nickels, L., Copland, D., Togher, L., Godecke, E., Meinzer, M., Rai, T., Cadilhac, D. A., Kim, J., Hurley, M., Foster, A., Carragher, M., Wilcox, C., Pierce, J. E., & Steel, G. (2022). Results of the COMPARE randomised controlled trial of Constraint Induced or Multi-modality Aphasia Therapy compared with usual care in chronic post-stroke aphasia. Journal of Neurology, Neurosurgery, and Psychiatry, 93(6), 573–581. https://doi.org/10.1136/jnnp-2021-328422